Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.
Clinical trial NCT02546674 · COMPLETED
Trial details
- NCT number
- NCT02546674
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-18
- Primary completion
- 2021-02-23
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.